Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17474-05-4

Post Buying Request

17474-05-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17474-05-4 Usage

Use

Synthetic intermediate in pharmaceuticals, agricultural chemicals, and dyes production

Physical Characteristics

Pale yellow solid

Thermal Stability

High

Solubility in Water

Low

Chemical Nature

Nitroaromatic compound

Hazards

Considered hazardous to human health and the environment

Handling and Disposal

Requires careful handling and disposal

Check Digit Verification of cas no

The CAS Registry Mumber 17474-05-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,4,7 and 4 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 17474-05:
(7*1)+(6*7)+(5*4)+(4*7)+(3*4)+(2*0)+(1*5)=114
114 % 10 = 4
So 17474-05-4 is a valid CAS Registry Number.

17474-05-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-dinitro-N-phenyl-4-(trifluoromethyl)aniline

1.2 Other means of identification

Product number -
Other names (Dinitro-trifluoromethyl-phenyl)-phenyl-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17474-05-4 SDS

17474-05-4Downstream Products

17474-05-4Relevant articles and documents

Solvent and substituent effects on the reaction of 2- and 4-chloro-3,5-dinitrobenzotrifluorides with substituted anilines

Asghar, Basim H.M.,Fathalla, Magda F.,Hamed, Ezzat A.

supporting information; experimental part, p. 777 - 786 (2010/07/02)

The solvent effect on a nucleophilic substitution reaction of 2- and 4-chloro-3,5- dinitrobenzotrifluoride with substituted anilines was studied in methanol, acetonitrile, and toluene at 25°C. This reaction is of second order, except 2-chloro-3,5-dinitrobenzotrifluoride in toluene shows third order. The kA values are found to be dependent on the substituent in aniline and give good Hammett correlations. The obtained ρ values are -4.07 and -4.62, for the reaction of anilines with 2-chloro-3,5- dinitrobenzotrifluoride in methanol and acetonitrile, respectively. The ρ values for the reaction of the anilines with 4-chloro-3,5- dinitrobenzotrifluoride are-3.38,-4.11, and-4.34 in methanol, acetonitrile, and toluene, respectively. The reaction of the former compound with anilines in toluene shows a second order in aniline. The dependence of the reaction on the external base such as DABCO suggests a proton transfer controlling step.

Synthesis and evaluation of dinitroanilines for treatment of cryptosporidiosis

Benbow, John W.,Bernberg, Erin L.,Korda, Anna,Mead, Jan R.

, p. 339 - 343 (2007/10/03)

The efficacy of a series of dinitroaniline herbicide derivatives for the treatment of Cryptosporidium parvum infections has been studied. The lead compounds oryzalin (compound 1) and trifluralin (compound 2) have low water solubility (3 ppm) which was alleged to be a major contributor to their poor pharmacokinetic availability. Derivatives of compounds 1 and 2 were synthesized. In these derivatives the functionality at the C-1 amine position or the C-4 position was substituted with groups with various hydrophilicities to determine if a direct relation existed between water solubility and overall activity. The chlorinated precursors of these derivatives were also examined and were found to be less active in the C. parvum assays, a result in direct contrast to earlier work with Leishmania. Enhanced water solubility alone did not overcome the drug availability problem; however, several candidates with similar activities but with toxicities lower than those of the lead compounds were produced.

Benzimidazole compounds

-

, (2008/06/13)

The present patent application discloses compounds having the formula STR1 or a pharmaceutically acceptable salt thereof wherein R 3, R 4, R 6 and R 7 each have the meanings set forth in the specification.The compounds are useful for the treatment of various central nervous system disorders such as epilepsy and other convulsive disorders, anxiety, sleep disorders and memory disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17474-05-4